Side-by-side comparison of AI visibility scores, market position, and capabilities
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
SF YC AI test automation at $1M ARR Dec 2024 with 5 employees; ex-Google/Uber founders with self-healing tests that auto-repair when UI changes helping OpenArt scale to $16M ARR competing with Mabl for zero-flakiness CI testing.
Stably AI is a San Francisco-based AI test automation platform — backed by Y Combinator — reaching $1 million in annual revenue in December 2024 with a 5-person team — providing engineering teams with an AI platform that auto-generates, runs, and maintains end-to-end tests in CI/CD pipelines with zero-flakiness guarantees and self-healing capabilities that automatically repair tests when UIs change, replacing the brittle Playwright and Cypress test suites that break with every UI update. Founded in 2023 by ex-Google Chrome infrastructure engineer Jinjing Liang (CEO) and ex-Uber Safety ML engineer Neil Parker (CTO), Stably enables customers like OpenArt (which scaled to $16M ARR with a 10-person engineering team using Stably) to achieve test coverage without dedicated QA engineers.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.